Shengtao Yuan

机构：China Pharmaceutical University, Cornell University · ORCID：0000-0002-5626-6532

发表论文 127 篇 · 总被引 4665 次 · h-index 37

代表论文

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma (2021 · Acta Pharmaceutica Sinica B · 被引 658)
Metabolism and polarization regulation of macrophages in the tumor microenvironment (2022 · Cancer Letters · 被引 100)
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells (2022 · World Journal of Surgical Oncology · 被引 62)
TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma (2021 · Biochemical and Biophysical Research Communications · 被引 46)
Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease (2022 · Acta Pharmaceutica Sinica B · 被引 34)
A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer (2023 · Cancers · 被引 21)